HQ Function

The Australian headquarters serves as the company's main corporate office, overseeing global strategy, financial management, ASX compliance, investor relations, and coordination of Australian-based research and clinical activities.

Notable Features:

Modern office facilities within a recognized commercial building, designed to support administrative, strategic, and collaborative functions. Proximity to Melbourne's renowned biomedical research and academic institutions.

Work Culture:

A dynamic and mission-driven work culture focused on scientific excellence, innovation, and collaboration. Employees are typically passionate about advancing cell therapies to address unmet needs in oncology, working in a fast-paced, results-oriented environment.

HQ Significance:

The Melbourne headquarters anchors Chimeric Therapeutics' operations as an Australian publicly listed company, facilitating access to local capital markets and the vibrant Australian biotechnology ecosystem, while supporting its global clinical development programs.

Values Reflected in HQ: The headquarters' location in a major Australian city reflects a commitment to accessing skilled talent, fostering collaborations within the local and international biotech community, and maintaining a strong corporate and governance presence as an ASX-listed entity.

Location:

Chimeric Therapeutics maintains a focused global presence, with its corporate headquarters in Australia and significant clinical development operations, research activities, and strategic partnerships primarily centered in the United States. The company is actively conducting multi-site clinical trials in both Australia and the U.S. to advance its pipeline of CAR T and CAR NK cell therapies for cancer patients worldwide.

Street Address:

Level 3, 62 Lygon Street

City:

Carlton

State/Province:

VIC

Country:

Australia